|
Market Cap (4-Jul) $8,036,723,200 (204th) |
Close (30-Jun) $11.22 |
Volume (30-Jun) 664,557 |
Shortsold (19-Jun) 16,724,445 (4.94%) (48th) |
|
52w High $31.97 |
52w Low $17.03 |
P/E 54.95 |
EPS 0.14 |
TLX released this announcement to the ASX on 18 August 2022, 8:09. The announcement is not marked as price sensitive, and is 39 page(s) in length and 4.2MB in size.
You can view all announcements from TLX and see how they appear on a price chart on the announcements page.
At the date of this announcement, TLX was 0.867% short sold according to ASIC data. It was ranked the 229th most shorted stock on the ASX. It is now ranked as the 48th most shorted stock on the ASX with 4.944% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from TLX | |
|---|---|
| Cleansing Notice | 28 June 2023, 8:23 |
| Application for quotation of securities - TLX | 28 June 2023, 8:23 |
| Proposed issue of securities - TLX | 21 June 2023, 18:12 |
| 2022 Interim Report | 18 August 2022, 8:09 |
| Appendix 4D - Results for announcement to the market | 18 August 2022, 8:08 |
| Grand Pharmaceutical Group's investment in Telix | 15 August 2022, 8:14 |
| Telix 1H 2022 Financial Results Investor Call Notification | 5 August 2022, 8:22 |
You must be logged in to post a reply.
Telix Pharmaceuticals 